Osteoprotegerin, soluble receptor activator of nuclear factor- B ligand, and subclinical atherosclerosis in children and adolescents with Type 1 Diabetes Mellitus

International Journal of Endocrinology

Volumn 2013, Issue , 2013, Pages

  Lambrinoudaki, Irene ^a   Tsouvalas, Emmanouil ^b   Vakaki, Marina ^c   Kaparos, George ^a   Stamatelopoulos, Kimon ^b   Augoulea, Areti ^a   Pliatsika, Paraskevi ^a   Alexandrou, Andreas ^a   Creatsa, Maria ^a   Karavanaki, Kyriaki ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c P AND A KYRIAKOU CHILDREN S HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PROTEIN; TRIACYLGLYCEROL; UREA;

ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CHILD; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD; TRIACYLGLYCEROL BLOOD LEVEL; UREA BLOOD LEVEL;

EID: 84888875524     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2013/102120     Document Type: Article

References (40)

1. Shah P. K., Screening asymptomatic subjects for subclinical atherosclerosis. Can we, does it matter, and should we? Journal of the American College of Cardiology 2010 56 2 98 105 2-s2.0-77953904713 10.1016/j.jacc.2009. 09.081
2. Järvisalo M. J., Jartti L., Näntö-Salonen K., Irjala K., Rönnemaa T., Hartiala J. J., Celermajer D. S., Raitakari O. T., Increased aortic intima-media thickness: a marker of preclinical atherosclerosis in high-risk children. Circulation 2001 104 24 2943 2947 2-s2.0-0035846615 (Pubitemid 33139107)
3. Dahl-Jørgensen K., Larsen J. R., Hanssen K. F., Atherosclerosis in childhood and adolescent type 1 diabetes: early disease, early treatment? Diabetologia 2005 48 8 1445 1453 2-s2.0-23844485882 10.1007/s00125-005-1832-1 (Pubitemid 41175493)
4. Pozza R. D., Bechtold S., Bonfig W., Putzker S., Kozlik-Feldmann R., Netz H., Schwarz H., Age of onset of type 1 diabetes in children and carotid intima medial thickness. Journal of Clinical Endocrinology and Metabolism 2007 92 6 2053 2057 2-s2.0-34347258542 10.1210/jc.2006-2868 (Pubitemid 46997100)
5. McVeigh G. E., Gibson W., Hamilton P. K., Cardiovascular risk in the young type 1 diabetes population with a low 10-year, but high lifetime risk of cardiovascular disease. Diabetes, Obesity and Metabolism 2013 15 3 198 203 10.1111/dom.12013
6. Berenson G. S., Childhood risk factors predict adult risk associated with subclinical cardiovascular disease: the Bogalusa heart study. The American Journal of Cardiology 2002 90 10 3L 7L 2-s2.0-0037153060 (Pubitemid 35379896)
7. Margeirsdottir H. D., Stensaeth K. H., Larsen J. R., Brunborg C., Dahl-Jørgensen K., Early signs of atherosclerosis in diabetic children on intensive insulin treatment: a population-based study. Diabetes Care 2010 33 9 2043 2048 2-s2.0-79951629408 10.2337/dc10-0505
8. Järvisalo M. J., Lehtimäki T., Raitakari O. T., Determinants of arterial nitrate-mediated dilatation in children: role of oxidized low-density lipoprotein, endothelial function, and carotid intima-media thickness. Circulation 2004 109 23 2885 2889 2-s2.0-2942640282 10.1161/01.CIR.0000129304. 98566.D8 (Pubitemid 38780303)
9. Urbina E. M., Williams R. V., Alpert B. S., Collins R. T., Daniels S. R., Hayman L., Jacobson M., Mahoney L., Mietus-Snyder M., Rocchini A., Steinberger J., McCrindle B., Noninvasive assessment of subclinical atherosclerosis in children and adolescents: recommendations for standard assessment for clinical research: a scientific statement from the american heart association. Hypertension 2009 54 5 919 950 2-s2.0-70449709433 10.1161/HYPERTENSIONAHA.109. 192639
10. Yavuz T., Akcay A., Omeroglu R. E., Bundak R., Sukur M., Ultrasonic evaluation of early atherosclerosis in children and adolescents with type 1 diabetes mellitus. Journal of Pediatric Endocrinology and Metabolism 2002 15 8 1131 1136 (Pubitemid 35153651)
11. van Campenhout A., Golledge J., Osteoprotegerin, vascular calcification and atherosclerosis. Atherosclerosis 2009 204 2 321 329 2-s2.0-67349099856 10.1016/j.atherosclerosis.2008.09.033
12. Galluzzi F., Stagi S., Salti R., Toni S., Piscitelli E., Simonini G., Falcini F., Chiarelli F., Osteoprotegerin serum levels in children with type 1 diabetes: a potential modulating role in bone status. European Journal of Endocrinology 2005 153 6 879 885 2-s2.0-29644447888 10.1530/eje.1.02052 (Pubitemid 43020239)
13. Alberti K. G., Zimmet P. Z., Definition, diagnosis and classification of diabetes mellitus and its complications-part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Medicine 1998 15 7 539 553 10.1002/(SICI)1096-9136(199807)15:7<539::AID- DIA668>3.0.CO;2-S (Pubitemid 28319935)
14. Lau K. H., Fung Y. K., Cheung Y. T., Tsang W. K., Ying M., Repeatability and reproducibility of ultrasonographic measurement of carotid intima thickness. Journal of Clinical Ultrasound 2012 40 2 79 84 2-s2.0-84855615009 10.1002/jcu.20906
15. Singh T. P., Groehn H., Kazmers A., Vascular function and carotid intimal-medial thickness in children with insulin-dependent diabetes mellitus. Journal of the American College of Cardiology 2003 41 4 661 665 2-s2.0-0037454013 10.1016/S0735-1097(02)02894-2 (Pubitemid 36223334)
16. Lamotte C., Iliescu C., Libersa C., Gottrand F., Increased intima-media thickness of the carotid artery in childhood: a systematic review of observational studies. European Journal of Pediatrics 2011 170 6 719 729 2-s2.0-79959774271 10.1007/s00431-010-1328-y
17. Parikh A., Sochett E. B., McCrindle B. W., Dipchand A., Daneman A., Daneman D., Carotid artery distensibility and cardiac function in adolescents with type 1 diabetes. Journal of Pediatrics 2000 137 4 465 469 2-s2.0-0033765171
18. Gunczler P., Lanes R., Lopez E., Esaa S., Villarroel O., Revel-Chion R., Cardiac mass and function, carotid artery intima-media thickness and lipoprotein (a) levels in children and adolescents with type 1 diabetes mellitus of short duration. Journal of Pediatric Endocrinology and Metabolism 2002 15 2 181 186 2-s2.0-0036002593 (Pubitemid 34704792)
19. Dawson J. D., Sonka M., Blecha M. B., Lin W., Davis P. H., Risk factors associated with aortic and carotid intima-media thickness in adolescents and young adults: the muscatine offspring study. Journal of the American College of Cardiology 2009 53 24 2273 2279 2-s2.0-67649909241
20. Jourdan C., Wühl E., Litwin M., Fahr K., Trelewicz J., Jobs K., Schenk J., Grenda R., Mehls O., Tröger J., Schaefer F., Normative values for intima-media thickness and distensibility of large arteries in healthy adolescents. Journal of Hypertension 2005 23 9 1707 1715 2-s2.0-24144502355 (Pubitemid 41233431)
21. Freedman D. S., Patel D. A., Srinivasan S. R., Chen W., Tang R., Bond M. G., Berenson G. S., The contribution of childhood obesity to adult carotid intima-media thickness: the Bogalusa heart study. International Journal of Obesity 2008 32 5 749 756 2-s2.0-43449110923 10.1038/sj.ijo.0803798 (Pubitemid 351670622)
22. Kilpatrick E. S., Rigby A. S., Atkin S. L., Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: double diabetes in the diabetes control and complications trial. Diabetes Care 2007 30 3 707 712 2-s2.0-33847611626 10.2337/dc06-1982 (Pubitemid 46354357)
23. Findlay D. M., Atkins G. J., Relationship between serum RANKL and RANKL in bone. Osteoporosis International 2011 22 10 2597 2602 2-s2.0-80755172240 10.1007/s00198-011-1740-9
24. Blázquez-Medela A. M., García-Ortiz L., Gómez-Marcos M. A., Recio-Rodriguez J. I., Sánchez-Rodríguez A., López-Novoa J. M., Martínez-Salgado C., Osteoprotegerin is associated with cardiovascular risk in hypertension and/or diabetes. European Journal of Clinical Investigation 2012 42 5 548 556 2-s2.0-84859718967 10.1111/j.1365-2362.2011.02619.x
25. Xiang G. D., Sun H. L., Zhao L. S., Changes of osteoprotegerin before and after insulin therapy in type 1 diabetic patients. Diabetes Research and Clinical Practice 2007 76 2 199 206 2-s2.0-33947142839 10.1016/j.diabres.2006. 09.008 (Pubitemid 46400128)
26. Rasmussen L. M., Tarnow L., Hansen T. K., Parving H. H., Flyvbjerg A., Plasma osteoprotegerin levels are associated with glycaemic status, systolic blood pressure, kidney function and cardiovascular mordibity in type 1 diabetic patients. European Journal of Endocrinology 2006 154 1 75 81 2-s2.0-32844472729 10.1530/eje.1.02049 (Pubitemid 43250739)
27. Akinci B., Demir T., Celtik A., Baris M., Yener S., Ozcan M. A., Yuksel F., Secil M., Yesil S., Serum osteoprotegerin is associated with carotid intima media thickness in women with previous gestational diabetes. Diabetes Research and Clinical Practice 2008 82 2 172 178 2-s2.0-54549097963 10.1016/j.diabres. 2008.07.014
28. Holecki M., Zahorska-Markiewicz B., Janowska J., Nieszporek T., Wojaczyńska-Stanek K., Zak-Gołb A., Wicek A., The influence of weight loss on serum osteoprotegerin concentration in obese perimenopausal women. Obesity 2007 15 8 1925 1929 2-s2.0-34548603203 10.1038/oby.2007.229 (Pubitemid 47402223)
29. Vik A., Mathiesen E. B., Johnsen S. H., Brox J., Wilsgaard T., Njølstad I., Hansen J.-., Serum osteoprotegerin, sRANKL and carotid plaque formation and growth in a general population-the Tromsø study. Journal of Thrombosis and Haemostasis 2010 8 5 898 905 2-s2.0-77953774003 10.1111/j.1538-7836.2010.03790.x
30. Dimitri P., Wales J. K., Bishop N., Adipokines, bone-derived factors and bone turnover in obese children; evidence for altered fat-bone signalling resulting in reduced bone mass. Bone 2011 48 2 189 196 2-s2.0-78650969568 10.1016/j.bone.2010.09.034
31. Wasilewska A., Rybi-Szuminska A. A., Zoch-Zwierz W., Serum osteoprotegrin (OPG) and receptor activator of nuclear factor B (RANKL) in healthy children and adolescents. Journal of Pediatric Endocrinology and Metabolism 2009 22 12 1099 1104 2-s2.0-77349097340
32. Buzi F., Maccarinellif G., Guaragni B., Ruggeri F., Radetti G., Meini A., Mazzolari E., Cocchi D., Serum osteoprotegerin and receptor activator of nuclear factors kB (RANKL) concentrations in normal children and in children with pubertal precocity, Turner's syndrome and rheumatoid arthritis. Clinical Endocrinology 2004 60 1 87 91 2-s2.0-0842287654 10.1111/j.1365-2265.2004.01951.x (Pubitemid 38183503)
33. Oh E. S., Rhee E., Oh K. W., Lee W. Y., Baek K. H., Yoon K. H., Kang M. I., Yun E. J., Park C. Y., Choi M. G., Yoo H. J., Park S. W., Circulating osteoprotegerin levels are associated with age, waist-to-hip ratio, serum total cholesterol, and low-density lipoprotein cholesterol levels in healthy Korean women. Metabolism 2005 54 1 49 54 2-s2.0-9644284520 10.1016/j.metabol.2004.08. 005 (Pubitemid 39572456)
34. Gannagé-Yared M. H., Yaghi C., Habre B., Khalife S., Noun R., Germanos-Haddad M., Trak-Smayra V., Osteoprotegerin in relation to body weight, lipid parameters insulin sensitivity, adipocytokines, and C-reactive protein in obese and non-obese young individuals: results from both cross-sectional and interventional study. European Journal of Endocrinology 2008 158 3 353 359 2-s2.0-40949106785 10.1530/EJE-07-0797 (Pubitemid 351405000)
35. Vik A., Mathiesen E. B., Brox J., Wilsgaard T., Njølstad I., Jørgensen L., Hansen J., Relation between serum osteoprotegerin and carotid intima media thickness in a general population-the Tromsø study. Journal of Thrombosis and Haemostasis 2010 8 10 2133 2139 2-s2.0-78649343556 10.1111/j.1538-7836.2010.03990.x
36. Kiechl S., Schett G., Wenning G., Redlich K., Oberhollenzer M., Mayr A., Santer P., Smolen J., Poewe W., Willeit J., Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease. Circulation 2004 109 18 2175 2180 2-s2.0-2442492972 10.1161/01.CIR.0000127957.43874.BB (Pubitemid 38625393)
37. Kim S. M., Leet J., Ryu O. H., Lee K. W., Kim H. Y., Seo J. A., Kim S. G., Kim N. H., Baik S. H., Choi D. S., Choi K. M., Serum osteoprotegerin levels are associated with inflammation and pulse wave velocity. Clinical Endocrinology 2005 63 5 594 598 2-s2.0-27744564963 10.1111/j.1365-2265.2005.02390.x (Pubitemid 41626757)
38. Siepi D., Marchesi S., Vaudo G., Lupattelli G., Bagaglia F., Pirro M., Brozzetti M., Roscini A. R., Mannarino E., Preclinical vascular damage in white postmenopausal women: the relevance of osteoprotegerin. Metabolism 2008 57 3 321 325 2-s2.0-38749092671 10.1016/j.metabol.2007.10.005 (Pubitemid 351178720)
39. Kiechl S., Schett G., Schwaiger J., Seppi K., Eder P., Egger G., Santer P., Mayr A., Xu Q., Willeit J., Soluble receptor activator of nuclear factor- B ligand and risk for cardiovascular disease. Circulation 2007 116 4 385 391 2-s2.0-34547574967 10.1161/CIRCULATIONAHA.106.686774 (Pubitemid 47196543)
40. Wagner D., Fahrleitner-Pammer A., Levels of osteoprotegerin (OPG) and receptor activator for nuclear factor B ligand (RANKL) in serum: are they of any help? Wiener Medizinische Wochenschrift 2010 160 17-18 452 457 2-s2.0-78149407953 10.1007/s10354-010-0818-x